No revascularisation (n=106) | Percutaneous coronary intervention (n=11) | p Value | |
---|---|---|---|
Aspirin | 106 (100%) | 11 (100%) | 1 |
Clopidogrel/ticagrelor/prasugrel | 100 (94%) | 11 (100%) | 0.4 |
ACE inhibitors/angiotensin receptor blockers | 55 (52%) | 11 (100%) | 0.002 |
β-Blockers | 97 (91.5%) | 9 (82%) | 0.3 |
Calcium channel blockers | 80 (75%) | 8 (73%) | 0.8 |
Nitrates | 63 (59%) | 7 (64%) | 0.8 |
Nicorandil | 39 (37%) | 1 (9%) | 0.06 |
Statins | 102 (96%) | 11 (100%) | 0.5 |